| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pubmed | 7.28e-06 | 21 | 7 | 2 | 21509594 | ||
| Pubmed | 2.14e-04 | 112 | 7 | 2 | 24344204 | ||
| Pubmed | 1.69e-03 | 317 | 7 | 2 | 11042152 | ||
| Pubmed | Systematic identification of pathological lamin A interactors. | 1.90e-03 | 337 | 7 | 2 | 24623722 | |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 2.46e-03 | 384 | 7 | 2 | 31059266 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 2.80e-03 | 410 | 7 | 2 | 26949251 | |
| Pubmed | Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function. | 2.84e-03 | 413 | 7 | 2 | 27499296 | |
| Pubmed | 3.46e-03 | 457 | 7 | 2 | 22190034 | ||
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.88e-04 | 168 | 7 | 2 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.91e-04 | 169 | 7 | 2 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.98e-04 | 171 | 7 | 2 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.19e-04 | 177 | 7 | 2 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-04 | 178 | 7 | 2 | 5cf12927f0756c4d8a289fe4308d736382e6212e | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.60e-04 | 188 | 7 | 2 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.71e-04 | 191 | 7 | 2 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-04 | 192 | 7 | 2 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-04 | 192 | 7 | 2 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-04 | 192 | 7 | 2 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.79e-04 | 193 | 7 | 2 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.83e-04 | 194 | 7 | 2 | c53478057674d70b79df8a3f476d15dea1925753 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.83e-04 | 194 | 7 | 2 | 2ab3f75b795a0ee4fe0f8eeba33093fcc77935f5 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.83e-04 | 194 | 7 | 2 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.83e-04 | 194 | 7 | 2 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.83e-04 | 194 | 7 | 2 | 8805c90e4284a81a6c8078f2d2417ae77b4e5c63 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.83e-04 | 194 | 7 | 2 | 86d52467b05a0018517377c9c441245501f71d91 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-04 | 194 | 7 | 2 | 70a61b74f1c01abc6f8779b564faae508895a18e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-04 | 195 | 7 | 2 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-04 | 195 | 7 | 2 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|Epithelial_cells / Location, Cell class and cell subclass | 3.87e-04 | 195 | 7 | 2 | a3e2999fdd4c3575add6e28ecfd1d6606a61f992 | |
| ToppCell | 10x3'2.3-week_12-13|World / cell types per 3 fetal stages;per 3',per 5' | 3.87e-04 | 195 | 7 | 2 | 458a802a0123fe1b2d75f4866ebdb46096cf52e2 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-04 | 195 | 7 | 2 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-04 | 195 | 7 | 2 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM5|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.87e-04 | 195 | 7 | 2 | 6d768454ed630e586431535400507074eea76dd1 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 3.91e-04 | 196 | 7 | 2 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-04 | 197 | 7 | 2 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-04 | 197 | 7 | 2 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-04 | 197 | 7 | 2 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-04 | 197 | 7 | 2 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.99e-04 | 198 | 7 | 2 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.99e-04 | 198 | 7 | 2 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Tracheal-10x3prime_v2|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.99e-04 | 198 | 7 | 2 | e49862e8793b8b8b75af30bf0adabbc0d637554d | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.44e-03 | 192 | 7 | 2 | 2523_UP | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A | 1.46e-03 | 193 | 7 | 2 | 5839_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; PC3; HT_HG-U133A | 1.47e-03 | 194 | 7 | 2 | 4455_DN | |
| Drug | ST021200; Down 200; 10uM; PC3; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 7559_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 6708_DN | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 3740_DN | |
| Drug | Fluocinonide [356-12-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 3933_UP | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 5118_DN | |
| Drug | Tiletamine hydrochloride; Up 200; 15.4uM; PC3; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 7311_UP | |
| Drug | Ajmaline [4360-12-7]; Up 200; 12.2uM; HL60; HG-U133A | 1.52e-03 | 197 | 7 | 2 | 1749_UP | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 3990_DN | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 6341_DN | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 7096_DN | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 7307_DN | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 1811_UP | |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 5804_DN | |
| Drug | Methiothepin maleate [19728-88-2]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 6312_UP | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.57e-03 | 200 | 7 | 2 | 3765_DN |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AEKEKEMDPFHYDYQ | 21 | Q9H0Q3 | |
| GYMKLHPEDFPEEDK | 91 | O95298 | |
| YEKAPKEMEHVLDPD | 1436 | Q6ZVL6 | |
| DYEVMEDKEYKHPPE | 3906 | Q8WXX0 | |
| KIKAYPYMEGEPEDD | 71 | Q9BYD6 | |
| HSYFEKPKVDDEPMD | 381 | Q13123 | |
| DYEEPDPKMVELAKY | 601 | Q9H3U1 |